Oral drug combination extends progression-free survival in advanced ER-positive breast cancer

Published Date: 19 Oct 2025

Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with an oral combination regimen that includes giredestrant, a novel, next-generation ...

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Big Gain in PFS With Metastasis-Directed RT for Oligometastatic Pancreatic Cancer

2.

Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.

3.

Talk About Medication Costs, Bringing Back Touch, and Understanding From Dish Tumors.

4.

Year in Review: Multiple Myeloma

5.

Patients with metastatic breast cancer can predict their response to HER2-targeted therapy using whole-body PET/CT.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot